Medicine

Updated schema requirements are easy to mix up — here are a few simple solutions The post Common MRF Mistakes Hospitals Are Making in 2024 appeared first on MedCity News.

One of the most important things providers can do on the journey toward consumer-driven care is to check their paternalism at the door, said Nworah Ayogu, head of healthcare impact at Thrive Capital. The post These 3 Mindset Shifts Will Help Providers Deliver Consumer-Driven Care, Investor Says appeared first on MedCity News.

While AI has the potential to streamline processes, its current use in the revenue cycle is resulting in more claim denials, payment delays, and a greater need for appeals, particularly because payers often use AI to retroactively review medical necessity determinations. The post How Payers are Using AI to Deny Claims and Dent Provider Revenue…

Synapticure’s Series A round was led by B Capital and included participation from CommonSpirit Health, CVS Health Ventures and RA Capital. The post Synapticure Secures $25M To Scale Virtual Care for Neurodegenerative Diseases appeared first on MedCity News.

A committed, resilient future workforce starts by understanding the difference between an environment that sustains staff and one that actively invests in long-term engagement. The post Addressing Healthcare’s Retention Crisis by Understanding Gen Z appeared first on MedCity News.

Halozyme views its drug delivery technology for biologic medicines as complementary to Evotec’s biologic drug manufacturing capabilities. But according to Halozyme, Evotec was unwilling to engage in any merger discussions. The post Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy appeared first on MedCity News.

Seen Health emerged from stealth on Monday. The company builds on the Program of All-Inclusive Care for the Elderly model and focuses on Asian and Pacific Islander communities. The post Twin Brothers Launch Seen Health with $22M to Provide Culturally-Focused Care for Seniors appeared first on MedCity News.

During a recent panel discussion, three healthcare experts discussed reasons why value-based care is struggling to reach scale. The post Value-Based Care Is a Four Layer Cake — Why Do We Only Focus on The Icing? appeared first on MedCity News.

A patient death in a clinical trial usually prompts the FDA to impose a clinical hold. But Neurogene is able to avoid a lengthy clinical trial pause largely because of its participation in an FDA pilot program intended to speed up the development of therapies for rare diseases. The post Patient Dies in Gene Therapy…

By addressing each community’s unique needs with tailored, culturally responsive care and cross-sector collaboration, we can empower healthcare providers to drive lasting, equitable outcomes. The post Closing America’s Diabetes Divide: A $412 Billion Opportunity to Transform Diabetes Care appeared first on MedCity News.